Hamid Hassanzadeh

Dr. Hamid Hassanzadeh


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HHHamid Hassanzadeh
Hamid Hassanzadeh
JBJames Baber
James Baber
EBElizabeth Begier
Elizabeth Begier
DNDavid C Noriega
David C Noriega
HKHiroaki Konishi
Hiroaki Konishi
DLDavid Leaper
David Leaper
Staphylococcus aureus is a global pathogen that is frequently responsible for healthcare-associated infections, including surgical site infections (SSIs). Current infection prevention and control approaches may be limited, with S. aureus antibiotic resistance remaining problematic. Thus, a vaccine to prevent or reduce S. aureus infection is critically needed. We evaluated the efficacy and safety of an investigational 4-antigen S. aureus vaccine (SA4Ag) in adults undergoing elective open posterior spinal fusion procedures with multilevel instrumentation. In this multicenter, site-level, randomized, double-blind trial, patients aged 18–85 years received a single dose of SA4Ag or placebo 10–60 days before surgery. SA4Ag efficacy in preventing postoperative S. aureus bloodstream infection and/or deep incisional or organ/space SSIs was the primary end point. Safety evaluations included local reactions, systemic events, and adverse events (AEs). Immunogenicity and colonization were assessed. Study enrollment was halted when a prespecified interim efficacy analysis met predefined futility criteria. SA4Ag showed no efficacy (0.0%) in preventing postoperative S. aureus infection (14 cases in each group through postoperative day 90), despite inducing robust functional immune responses to each antigen compared with placebo. Colonization rates across groups were similar through postoperative day 180. Local reactions and systemic events were mostly mild or moderate in severity, with AEs reported at similar frequencies across groups. In patients undergoing elective spinal fusion surgical procedures, SA4Ag was safe and well tolerated but, despite eliciting substantial antibody responses that blocked key S. aureus virulence mechanisms, was not efficacious in preventing S. aureus infection. Clinical Trials Registration. NCT02388165.

26 October 2022 in Neurology International
Verified
Journal Article
Open access
PDF file
JWJoshua Wind
Joshua Wind
DPDaniel K Park
Daniel K Park
TLTodd Lansford
Todd Lansford
PNPierce Nunley
Pierce Nunley
TPTimothy Peppers
Timothy Peppers
JSJonathan Sales
Jonathan Sales
Background: While autologous bone grafts remain the gold standard for spinal fusion procedures, harvesting autologous bone is associated with significant complications, including donor site infection, hematomas, increased operative time, and prolonged pain. Cellular bone allograft (CBA) presents an alternative to autologous bone harvesting, with a favorable efficacy and safety profile. The current study further investigates CBA as an adjunct to lumbar spinal fusion procedures. Methods: A prospective, multicenter, open-label clinical study was conducted in subjects undergoing lumbar spinal fusion with CBA (NCT 02969616). Radiographic fusion status was assessed by an independent review of dynamic radiographs and CT scans. Clinical outcome measures included the Oswestry Disability Index (ODI) and visual analogue scale (VAS) for back and leg pain. Adverse-event reporting was conducted throughout 12 months of follow-up. Available subject data at 12 months were analyzed. Results: A total of 274 subjects were enrolled into the study, with available data from 201 subjects (73.3%) who completed 12 months of postoperative radiographic and clinical evaluation at the time of analysis. Subjects had a mean age of 60.2 ± 11.5 years. A higher number of women (n = 124, 61.7%) than men (n = 77, 38.3%) were enrolled, with a collective mean BMI of 30.6 + 6.5 kg/m2 (range 18.0–51.4). At month 12, successful fusion was achieved in 90.5% of subjects. A significant (p < 0.001) improvement in ODI, VAS-back, and VAS-leg clinical outcomes was also observed compared to baseline scores. One adverse event related to CBA (postoperative radiculopathy) was reported, with surgical exploration demonstrating interbody extrusion of graft material. This subject reported successful fusion at month 12. Conclusions: CBA represents a viable substitute for harvesting of autograft alone with a high rate of successful fusion and significant improvements in subject-reported outcomes, such as pain and disability. Positive benefit was observed in subjects reporting single and multiple risk factors for pseudoarthrosis.

25 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
JRJon Raso
Jon Raso
PKPramod N. Kamalapathy
Pramod N. Kamalapathy
VPVarun Puvanesarajah
Varun Puvanesarajah
LLLawal Labaran
Lawal Labaran
HHHamid Hassanzadeh
Hamid Hassanzadeh

22 February 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
JRJon Raso
Jon Raso
PKPramod N. Kamalapathy
Pramod N. Kamalapathy
LLLawal Labaran
Lawal Labaran
ASAnna Sumpter
Anna Sumpter
RRRana Rahman
Rana Rahman
HHHamid Hassanzadeh
Hamid Hassanzadeh

3 September 2024 in Clinical Spine Surgery
Verified
Journal Article
Closed access
ESEric Bs Solomon
Eric Bs Solomon
MGMihir Gupta
Mihir Gupta
RSRachel Bs Su
Rachel Bs Su
NRNolan Bs Reinhart
Nolan Bs Reinhart
VBValentina Bs Battistoni
Valentina Bs Battistoni
HHHamid Hassanzadeh
Hamid Hassanzadeh
Study Design: A systematic review. Objective: We characterized the rates of sociodemographic data and social determinants of health (SDOH) reported in spinal surgery randomized control trials (RCTs) and the association between these RCTs' characteristics and their rates of reporting on race, ethnicity, and SDOH variables. Summary of Background Data: Although numerous institutions maintain guidelines and recommendations regarding the inclusion and reporting of sociodemographic and SDOH variables in RCTs, the proportion of studies that ultimately report such information is unclear, particularly in spine surgery. Materials and Methods: We searched the MEDLINE, PubMed, and Embase databases for published results from spinal surgery RCTs from January 2002 through December 2022, and screened studies according to prespecified inclusion criteria regarding analysis and reporting of sociodemographic and SDOH variables. Results: We analyzed 421 studies. Ninety-six studies (22.8%) reported race, ethnicity, or SDOH covariates. On multivariate analysis, study size [rate ratio (RR)=1.18; 95% CI, 1.06–1.32], public/institutional funding (RR=2.28; 95% CI, 1.29–4.04), and private funding (RR=3.27; 95% CI, 1.87–5.74) were significantly associated with reporting race, ethnicity, or SDOH variables. Study size (RR=1.26; 95% CI, 1.07–1.48) and North American region (RR=21.84; CI, 5.04–94.64) were associated with a higher probability of reporting race and/or ethnicity. Finally, study size (RR=1.27; 95% CI, 1.10–1.46), public/institutional funding (RR=2.68; 95% CI, 1.33–5.39), focus on rehabilitation/therapy intervention (RR=2.70; 95% CI, 1.40–5.21), and nonblinded study groups (RR=2.70; 95% CI, 1.40–5.21) were associated with significantly higher probability of reporting employment status. Conclusion: Rates of reporting race, ethnicity, and SDOH variables were lower in the spinal surgery RCTs in our study than in RCTs in other medical disciplines. These reporting rates did not increase over a 20-year period. Trial characteristics significantly associated with higher rates of reporting were larger study size, North American region, private or public funding, and a focus on behavioral/rehabilitation interventions. Level of Evidence: Level III.

11 April 2024 in Clinical Spine Surgery
Verified
Journal Article
Open access
VPVikas Patel
Vikas Patel
JWJoshua Wind
Joshua Wind
IAIlyas Aleem
Ilyas Aleem
TLTodd Lansford
Todd Lansford
MWMarc A. Weinstein
Marc A. Weinstein
DCDomagoj Coric
Domagoj Coric
Study Design: A prospective multicenter clinical trial (NCT 03177473) was conducted with a retrospective cohort used as a control arm. Objective: The purpose of this study was to evaluate cervical spine fusion rates in subjects with risk factors for pseudarthrosis who received pulsed electromagnetic field (PEMF) treatment. Summary of Background Data: Certain risk factors predispose patients to pseudarthrosis, which is associated with prolonged pain, reduced function, and decreased quality of life. Methods: Subjects in the PEMF group were treated with PEMF for 6 months postoperatively. The primary outcome measure was fusion status at the 12-month follow-up period. Fusion status was determined using anterior/posterior, lateral, and flexion/extension radiographs and computed tomography (without contrast). Results: A total of 213 patients were evaluated (PEMF, n=160; Control, n=53). At baseline, the PEMF group had a higher percentage of subjects who used nicotine (P=0.01), had osteoporosis (P<0.05), multi-level disease (P65 years of age (P=0.01). The PEMF group showed over two-fold higher percentage of subjects that had ≥3 risk factors (n=92/160, 57.5%) compared with the control group (n=14/53, 26.4%). At the 12-month follow-up, the PEMF group demonstrated significantly higher fusion rates compared with the control (90.0% vs. 60.4%, P<0.05). A statistically significant improvement in fusion rate was observed in PEMF subjects with multi-level surgery (P30 kg/m2; P=0.0021) when compared with the control group. No significant safety concerns were observed. Conclusions: Adjunctive use of PEMF stimulation provides significant improvements in cervical spine fusion rates in subjects having risk factors for pseudarthrosis. When compared with control subjects that did not use PEMF stimulation, treated subjects showed improved fusion outcomes despite being older, having more risk factors for pseudarthrosis, and undergoing more complex surgeries.